Noberastine

This classification denotes a histamine-1 receptor antagonist with the molecular formula C17H21N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9HPD98OUWN, chemically known as 3h-imidazo(4,5-b)pyridin-2-amine, 3-((5-methyl-2-furanyl)methyl)-n-4-piperidinyl- but generally known as noberastine, which bears US NIH Compound Identifier 60531. European Medicines Agency schedules Noberastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09337MIG. The term NOBERASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). NOBERASTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule noberastine under HS 29349990 and SITC 51579. As of Q4 2014, NOBERASTINE remains the US FDA Preferred Term for this commodity. Noberastine bears US NLM identifiers UMLS ID C0132719 and NCI Concept Code C74582. SMILES: O1C(CN2C(NC3CCNCC3)NC3C2NCCC3)CCC1C.